Sio Capital Management as of Sept. 30, 2017
Portfolio Holdings for Sio Capital Management
Sio Capital Management holds 51 positions in its portfolio as reported in the September 2017 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Axovant Sciences | 17.0 | $33M | 4.8M | 6.88 | |
Sage Therapeutics (SAGE) | 6.2 | $12M | 190k | 62.30 | |
Quotient | 6.0 | $12M | 2.3M | 4.93 | |
GlaxoSmithKline | 5.7 | $11M | 272k | 40.60 | |
Adamis Pharmaceuticals Corp Com Stk | 5.2 | $10M | 1.9M | 5.22 | |
Insmed (INSM) | 4.3 | $8.3M | 267k | 31.21 | |
Aetna | 4.2 | $8.0M | 51k | 159.02 | |
Agios Pharmaceuticals (AGIO) | 2.9 | $5.5M | 83k | 66.75 | |
Seattle Genetics | 2.8 | $5.4M | 100k | 54.41 | |
Biogen Idec (BIIB) | 2.5 | $4.9M | 16k | 313.14 | |
Globus Med Inc cl a (GMED) | 2.3 | $4.4M | 147k | 29.72 | |
Medtronic (MDT) | 2.2 | $4.3M | 56k | 77.77 | |
Kura Oncology (KURA) | 2.1 | $4.1M | 276k | 14.95 | |
Rigel Pharmaceuticals (RIGL) | 2.1 | $4.0M | 1.6M | 2.54 | |
Halyard Health | 2.0 | $3.9M | 87k | 45.03 | |
Eagle Pharmaceuticals (EGRX) | 2.0 | $3.8M | 64k | 59.64 | |
Zimmer Holdings (ZBH) | 1.9 | $3.6M | 31k | 117.10 | |
Emergent BioSolutions (EBS) | 1.9 | $3.7M | 90k | 40.45 | |
Advanced Accelerat spon ads each rep 2 ord | 1.9 | $3.6M | 53k | 67.63 | |
Puma Biotechnology (PBYI) | 1.7 | $3.3M | 27k | 119.76 | |
Zoetis Inc Cl A (ZTS) | 1.6 | $3.2M | 50k | 63.76 | |
Koninklijke Philips Electronics NV (PHG) | 1.4 | $2.8M | 68k | 41.21 | |
Icon (ICLR) | 1.4 | $2.7M | 24k | 113.88 | |
Intuitive Surgical (ISRG) | 1.4 | $2.6M | 2.5k | 1046.00 | |
Integer Hldgs (ITGR) | 1.4 | $2.6M | 51k | 51.15 | |
Anthem (ELV) | 1.3 | $2.5M | 13k | 189.89 | |
Alnylam Pharmaceuticals (ALNY) | 1.2 | $2.4M | 20k | 117.48 | |
Luminex Corporation | 1.2 | $2.4M | 116k | 20.33 | |
Vertex Pharmaceuticals Incorporated (VRTX) | 1.2 | $2.3M | 15k | 152.01 | |
Sanofi-Aventis SA (SNY) | 1.2 | $2.2M | 45k | 49.78 | |
UnitedHealth (UNH) | 1.2 | $2.2M | 11k | 195.89 | |
Catalyst Biosciences | 1.1 | $2.1M | 422k | 5.06 | |
Arena Pharmaceuticals | 0.9 | $1.8M | 72k | 25.50 | |
Vocera Communications | 0.9 | $1.8M | 56k | 31.37 | |
Evolent Health (EVH) | 0.7 | $1.4M | 79k | 17.80 | |
Madrigal Pharmaceuticals (MDGL) | 0.6 | $1.2M | 27k | 45.00 | |
Flamel Technologies Sa (AVDL) | 0.5 | $960k | 91k | 10.50 | |
Actinium Pharmaceuticals | 0.5 | $922k | 1.6M | 0.58 | |
Foamix Pharmaceuticals | 0.4 | $773k | 139k | 5.55 | |
Dbv Technologies S A (DBVT) | 0.4 | $772k | 18k | 42.42 | |
Xencor (XNCR) | 0.4 | $759k | 33k | 22.93 | |
Progenics Pharmaceuticals | 0.3 | $652k | 89k | 7.37 | |
Acadia Healthcare (ACHC) | 0.3 | $659k | 14k | 47.75 | |
Otonomy | 0.3 | $656k | 202k | 3.25 | |
Aeglea Biotherapeutics | 0.3 | $639k | 130k | 4.93 | |
Cymabay Therapeutics | 0.3 | $605k | 75k | 8.07 | |
Pfenex | 0.1 | $259k | 86k | 3.02 | |
Oasmia Pharmaceutical Ab | 0.1 | $211k | 203k | 1.04 | |
Chemocentryx | 0.1 | $187k | 25k | 7.43 | |
Steadymed | 0.1 | $184k | 55k | 3.35 | |
Sunesis Pharmaceuticals Inc Ne | 0.0 | $65k | 34k | 1.93 |